Johnson & Johnson (NYSE: JNJ) released its fourth-quarter earnings on Jan. 22. The results were mixed, with earnings per share of $1.88, which came in above analyst expectations of $1.87 despite its top line of $20.74 billion missing Wall Street's estimates of $20.8 billion. The stock was initially down around 2% on the results but it has since climbed back up.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,